関連する実験動画
Updated: Jan 29, 2026

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.4K
薬剤の薬理動力学と毒性に対する宿主と微生物の貢献を分離する
Michael Zimmermann1, Maria Zimmermann-Kogadeeva1, Rebekka Wegmann1
1Department of Microbial Pathogenesis and Microbial Sciences Institute, Yale University School of Medicine, New Haven, CT 06536, USA.
まとめ
この研究では,薬物の代謝における腸内微生物の役割を定量化し,微生物の活動と宿主因子を基に薬剤の有効性と毒性を予測するモデルを開発しました.
科学分野:
- 微生物学
- 薬理学について
- システム生物学
背景:
- 腸内微生物群は薬の代謝に大きく影響し,有効性と毒性に影響します.
- 宿主と微生物群が代謝経路を共有している場合,微生物の貢献を定量化することは困難です.
研究 の 目的:
- 薬物の代謝への微生物の貢献を予測するための定量モデルを開発する.
- 薬の変容における宿主と微生物の役割を解明するためです
主な方法:
- ブリブジンの代謝を研究するためにグノトバイオティクスを利用し,マウスの腸内共生遺伝学を行いました.
- 単一の微生物群にコードされた酵素が異なるマウスの組織における薬物の代謝を測定した.
- 生体利用度,宿主/微生物の活性,吸収,トランジット運動を統合した薬理学モデルを開発した.
主要な成果:
- 薬物とメタボリットの全身的暴露に対する微生物の貢献を成功裏にモデル化しました.
- このモデルは,重要な生理学的および酵素学的要因に基づいて微生物の影響を定量的に予測します.
- 複数の代謝経路を持つ薬である クロナゼパムの有効性を示しました
結論:
- 開発された薬理学モデルは,薬物の代謝に対する腸内微生物の影響を正確に予測します.
- このアプローチにより,薬剤の効能と毒性に対する微生物の貢献を正確に定量化することができます.
- この研究は,薬理学における宿主-微生物群の相互作用を理解するための枠組みを提供します.
さらに関連する動画
関連する概念動画
Pharmacokinetics: Drug–Drug Interactions
435
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
435
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
243
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
243
Pharmacokinetics in Pediatric Patients: Drug Excretion
259
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution
301
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
301
Pharmacokinetics in Pediatric Patients: Drug Metabolism
223
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
701
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701

